Sar9, Met (O2)11-Substance P is a neurokinin-1 receptor agonist. It is an analog of the naturally occurring human neuropeptide Substance P, which can be found throughout the body, including in the airways of humans and many other species.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Pegvisomant | Pegvisomant may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Mefloquine | Mefloquine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Tacrine | Tacrine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Sulpiride | Sulpiride may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Profenamine | Profenamine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Chlorpromazine | Chlorpromazine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Gallamine triethiodide | Gallamine triethiodide may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Triflupromazine | Triflupromazine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Cisplatin | Cisplatin may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Cinchocaine | Cinchocaine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Pyridostigmine | Pyridostigmine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Nizatidine | Nizatidine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Galantamine | Galantamine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Isoflurophate | Isoflurophate may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Diethylcarbamazine | Diethylcarbamazine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Procaine | Procaine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Minaprine | Minaprine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Donepezil | Donepezil may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Terbutaline | Terbutaline may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Mechlorethamine | Mechlorethamine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Hexafluronium | Hexafluronium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Demecarium | Demecarium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Physostigmine | Physostigmine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Rivastigmine | Rivastigmine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Edrophonium | Edrophonium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Procainamide | Procainamide may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Memantine | Memantine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Ambenonium | Ambenonium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Tubocurarine | Tubocurarine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Ketamine | Ketamine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Metoclopramide | Metoclopramide may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Decamethonium | Decamethonium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Pancuronium | Pancuronium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Pipecuronium | Pipecuronium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Ginkgo biloba | Ginkgo biloba may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Neostigmine | Neostigmine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Bambuterol | Bambuterol may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| 1,10-Phenanthroline | 1,10-Phenanthroline may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Thiotepa | Thiotepa may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Huperzine A | Huperzine A may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Phenserine | Phenserine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Regramostim | Regramostim may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Aprotinin | Aprotinin may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Betaine | Betaine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Capsaicin | Capsaicin may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Coumaphos | Coumaphos may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Dichlorvos | Dichlorvos may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Fenthion | Fenthion may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Metrifonate | Metrifonate may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Acotiamide | Acotiamide may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Methanesulfonyl Fluoride | Methanesulfonyl Fluoride may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Paraoxon | Paraoxon may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Tyrothricin | Tyrothricin may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Ipidacrine | Ipidacrine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Distigmine | Distigmine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Tretamine | Tretamine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Posiphen | Posiphen may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Methylphosphinic Acid | Methylphosphinic Acid may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Succinylcholine | The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Succinylcholine. |
| Cocaine | The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Cocaine. |
| Trimethaphan | The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Trimethaphan. |
| Doxacurium | The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Doxacurium. |
| Chloroprocaine | The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Chloroprocaine. |
| Ephedrine | The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Ephedrine. |
| Clevidipine | The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Clevidipine. |
| Mirabegron | The serum concentration of Mirabegron can be increased when it is combined with Sar9, Met (O2)11-Substance P. |
| Aclidinium | The serum concentration of Aclidinium can be increased when it is combined with Sar9, Met (O2)11-Substance P. |
| Moxisylyte | The serum concentration of Moxisylyte can be increased when it is combined with Sar9, Met (O2)11-Substance P. |
| Propacetamol | The serum concentration of Propacetamol can be increased when it is combined with Sar9, Met (O2)11-Substance P. |
| Butyrylthiocholine | The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Butyrylthiocholine. |
| Oxybuprocaine | The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Oxybuprocaine. |
| Benzonatate | The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Benzonatate. |
| Isoprenaline | Isoprenaline may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Isavuconazonium | The serum concentration of Isavuconazonium can be increased when it is combined with Sar9, Met (O2)11-Substance P. |
| Benzgalantamine | Benzgalantamine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |